High purity oritavancin and method of producing same

US9649352B2 · kind B2 · utility

Assignees

• THE MEDICINES COMPANY · US
• Abb Vie Inc. · US

Inventors

• Adel Rafai Far · Montréal, CA
• Gopal Krishna · Dover, US
• Min Ding · Dobbs Ferry, US
• Sanjay R. Chemburkar · Gurnee, US
• Carl M. Knable · North Chicago, US
• James P. Petzel · North Chicago, US
• Julie J. Pruyne · Gurnee, US
• Douglas M. Reamer · North Chicago, US

Key dates

• Filing date: Jul 16, 2015
• Grant date: May 16, 2017
• Expiry date: Jul 16, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12P21/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions.